Description: - A unique collection of 1810 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);- Bioactivity and safety confirmed by pre-clinical research evidence and clinical trials;- An effective tool for discovering new with old drugs and new drug target identification;- Covers various research areas: oncology, cardiology, anti-inflammatory, immunology, neuropsychiatry, analgesia etc- Structurally diverse, medicinally active, and cell permeable;- Rich documentation with structure, target, IC50 value and biological activity description;- NMR and HPLC/LCMS validated to ensure high purity.